Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 107814, 13 pages
http://dx.doi.org/10.1155/2015/107814
Research Article

Triptolide Attenuates Podocyte Injury by Regulating Expression of miRNA-344b-3p and miRNA-30b-3p in Rats with Adriamycin-Induced Nephropathy

1Department of Graduate School, Nanjing University of Chinese Medicine, Nanjing 210023, China
2Department of Nephrology, Suzhou Hospital of Chinese Medicine, Suzhou 215000, China
3The First Affiliated Hospital of Soochow University, Suzhou 21500, China
4Department of Nephrology, Wuxi No. 3 People’s Hospital, Wuxi 214000, China
5Department of Nephrology, Jiangsu Provincial Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China

Received 29 March 2015; Accepted 4 May 2015

Academic Editor: Guillermo Schmeda-Hirschmann

Copyright © 2015 Chun-Bo Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Z.-H. Liu, “Nephrology in China,” Nature Reviews Nephrology, vol. 9, no. 9, pp. 523–528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Patrakka and K. Tryggvason, “New insights into the role of podocytes in proteinuria,” Nature Reviews Nephrology, vol. 5, no. 8, pp. 463–468, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Matsusaka, E. Sandgren, A. Shintani et al., “Podocyte injury damages other podocytes,” Journal of the American Society of Nephrology, vol. 22, no. 7, pp. 1275–1285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Tryggvason, “Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm,” Journal of the American Society of Nephrology, vol. 10, no. 11, pp. 2440–2445, 1999. View at Google Scholar · View at Scopus
  5. S. Lehtonen, J. J. Ryan, K. Kudlicka, N. Iino, H. Zhou, and M. G. Farquhar, “Cell junction-associated proteins IQGAP1,MAGI-2,CASK, spectrins, and alpha-actinin are components of the nephrin multiproltein complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 28, pp. 9814–9819, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. G. I. Welsh and M. A. Saleem, “Nephrin-signature molecule of the glomerular podocyte?” Journal of Pathology, vol. 220, no. 3, pp. 328–337, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. Q. Liu, “Triptolide and its expanding multiple pharmacological functions,” International Immunopharmacology, vol. 11, no. 3, pp. 377–383, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Qui and P. N. Kao, “Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii hook. f,” Drugs in R & D, vol. 4, no. 1, pp. 1–18, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-X. Zheng, Z.-H. Chen, C.-H. Zeng, W.-S. Qin, L.-S. Li, and Z.-H. Liu, “Triptolide protects podocytes from puromycin aminonucleoside induced injury in vivo and in vitro,” Kidney International, vol. 74, no. 5, pp. 596–612, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. G. Wang, W. Sun, and Y. J. Zhen, “Preventive effect of multi-glycoside of tripterygium Wilfordii Hook.f. on proteinuria and mesangial injury in experimental mesangial proliferative glomerulonephritis,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 25, no. 9, pp. 817–821, 2005. View at Google Scholar
  11. T. N. MacKenzie, N. Mujumdar, S. Banerjee et al., “Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation,” Molecular Cancer Therapeutics, vol. 12, no. 7, pp. 1266–1275, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. H.-T. Meng, L. Zhu, W.-M. Ni, L.-S. You, J. Jin, and W.-B. Qian, “Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-κB activity and miR-16-1,” Acta Pharmacologica Sinica, vol. 32, no. 4, pp. 503–511, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. R. S. Poethig, A. Peragine, M. Yoshikawa, C. Hunter, M. Willmann, and G. Wu, “The function of RNAi in plant development,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 71, pp. 165–170, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Zhao and D. Srivastava, “A developmental view of microRNA function,” Trends in Biochemical Sciences, vol. 32, no. 4, pp. 189–197, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Yang, Z. Liu, F. Lu, A. Dong, and H. Huang, “SERRATE is a novel nuclear regulator in primary microRNA processing in Arabidopsis,” The Plant Journal, vol. 47, no. 6, pp. 841–850, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. A. A. Aboobaker, P. Tomancak, N. Patel, G. M. Rubin, and E. C. Lai, “Drosophila microRNAs exhibit diverse spatial expression patterns during embryonic development,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 50, pp. 18017–18022, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. R. C. Friedman, K. K.-H. Farh, C. B. Burge, and D. P. Bartel, “Most mammalian mRNAs are conserved targets of microRNAs,” Genome Research, vol. 19, no. 1, pp. 92–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Shkumatava, A. Stark, H. Sive, and D. P. Bartel, “Coherent but overlapping expression of microRNAs and their targets during vertebrate development,” Genes and Development, vol. 23, no. 4, pp. 466–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. B. John, A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks, “Human microRNA targets,” PLoS Biology, vol. 2, no. 11, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Hou and D. Zhao, “MicroRNA regulation in renal pathophysiology,” International Journal of Molecular Sciences, vol. 14, no. 7, pp. 13078–13092, 2013. View at Publisher · View at Google Scholar
  21. X. Xu, A. J. Kriegel, Y. Liu et al., “Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21,” Kidney International, vol. 82, no. 11, pp. 1167–1175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. F. Lan, H. H. Chen, P. F. Lai et al., “MicroRNA-494 reduces ATF3 expression and promotes AKI,” Journal of the American Society of Nephrology, vol. 23, no. 12, pp. 2012–2023, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Patel and L. Noureddine, “MicroRNAs and fibrosis,” Current Opinion in Nephrology and Hypertension, vol. 21, no. 4, pp. 410–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Bertani, A. Poggi, R. Pozzoni et al., “Adriamycin-induced nephrotic syndrome in rats,” Laboratory Investigation, vol. 46, no. 1, pp. 16–23, 1982. View at Google Scholar · View at Scopus
  25. A. B. Kramer, M. M. van Timmeren, T. A. Schuurs et al., “Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time,” The American Journal of Physiology: Renal Physiology, vol. 296, no. 5, pp. F1136–F1145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. L. Liang, J. B. Wu, J. M. Lai et al., “Protection effect of Zhen-Wu-Tang on adriamycin-induced nephrotic syndrome via inhibiting oxidative lesions and inflammation damage,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 131604, 11 pages, 2014. View at Publisher · View at Google Scholar
  27. Y. Qi, H. Xiao, C. Xu, X. Tian, H. Wu, and W. Shen, “Cyprinus carpio decoction improves nutrition and immunity and reduces proteinuria through nephrin and CD2AP expressions in rats with adriamycin-induced nephropathy,” Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 237482, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Liu, Z. Jiang, Y. Zhang et al., “Triptolide induces adverse effect on reproductive parameters of female Sprague-Dawley rats,” Drug and Chemical Toxicology, vol. 34, no. 1, pp. 1–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Li, J. Jin, M. Li et al., “Role of Nrf2 in protection against triptolide-induced toxicity in rat kidney cells,” Toxicology Letters, vol. 213, no. 2, pp. 194–202, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Asanuma and P. Mundel, “The role of podocytes in glomerular pathobiology,” Clinical and Experimental Nephrology, vol. 7, no. 4, pp. 255–259, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Nakhoul, R. Ramadan, E. Khankin et al., “Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies,” American Journal of Physiology: Renal Physiology, vol. 289, no. 4, pp. F880–F890, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A.-M. Kuusniemi, J. Merenmies, A.-T. Lahdenkari et al., “Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS1),” Kidney International, vol. 70, no. 8, pp. 1423–1431, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Zhang, J.-J. Zhang, J. Su, X.-M. Qi, Y.-G. Wu, and J.-J. Shen, “Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats,” American Journal of Chinese Medicine, vol. 37, no. 2, pp. 295–307, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Mao, Y. Zhang, L. Du, Y. Dai, C. Yang, and L. Liang, “Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy,” Pediatric Nephrology, vol. 21, no. 11, pp. 1666–1675, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. B. P. Lewis, C. B. Burge, and D. P. Bartel, “Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,” Cell, vol. 120, no. 1, pp. 15–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. K. P. Hoefig and V. Heissmeyer, “MicroRNAs grow up in the immune system,” Current Opinion in Immunology, vol. 20, no. 3, pp. 281–287, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Carleton, M. A. Cleary, and P. S. Linsley, “MicroRNAs and cell cycle regulation,” Cell Cycle, vol. 6, no. 17, pp. 2127–2132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. J. Sheetz and G. L. King, “Molecular understanding of hyperglycemia's adverse effects for diabetic complications,” Journal of the American Medical Association, vol. 288, no. 20, pp. 2579–2588, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Krupa, R. Jenkins, D. DongLuo, A. Lewis, A. Phillips, and D. Fraser, “Loss of microRNA-192 promotes fibrogenesis in diabetic nephropathy,” Journal of the American Society of Nephrology, vol. 21, no. 3, pp. 438–447, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. Wang, Y. Wang, A. W. Minto et al., “MicroRNA-377 is up-regulated and can lead to increased fibronection production in diabetic nephropathy,” The FASEB Journal, vol. 22, no. 12, pp. 4126–4135, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. Z. Zhang, H. Peng, J. Chen et al., “MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice,” FEBS Letters, vol. 583, no. 12, pp. 2009–2014, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. S.-O. Lee, T. Masyuk, P. Splinter et al., “MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease,” The Journal of Clinical Investigation, vol. 118, no. 11, pp. 3714–3724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. G. Wang, B. C.-H. Kwan, F. M.-M. Lai et al., “Intrarenal expression of miRNAs in patients with hypertensive nephrosclerosis,” American Journal of Hypertension, vol. 23, no. 1, pp. 78–84, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Naraba and N. Iwai, “Assessment of the MicroRNA system in salt-sensitive hypertension,” Hypertension Research, vol. 28, no. 10, pp. 819–826, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Shi, L. Yu, C. Chiu et al., “Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis,” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2159–2169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Luo, C. Wang, X. Chen et al., “Increased serum and urinary MicroRNAs in children with idiopathic nephrotic syndrome,” Clinical Chemistry, vol. 59, no. 4, pp. 658–666, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Chen, S. Wang, L. Chen et al., “MicroRNA-344 inhibits 3T3-L1 cell differentiation via targeting GSK3β of Wnt/β-catenin signaling pathway,” FEBS Letters, vol. 588, no. 3, pp. 429–435, 2014. View at Publisher · View at Google Scholar · View at Scopus